Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

[1]  David T. Jones,et al.  Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity , 2013, Neurology.

[2]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[3]  Kewei Chen,et al.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.

[4]  M. Mielke,et al.  Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease? , 2012, Clinical lipidology.

[5]  C. Lyketsos,et al.  Serum ceramides increase the risk of Alzheimer disease , 2012, Neurology.

[6]  H. Zetterberg,et al.  Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease , 2012, Neuroscience Letters.

[7]  R. Pepperkok,et al.  Molecular recognition of a single sphingolipid species by a protein’s transmembrane domain , 2012, Nature.

[8]  Xianlin Han,et al.  Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics , 2011, PloS one.

[9]  P. Saftig,et al.  Sphingolipid Storage Affects Autophagic Metabolism of the Amyloid Precursor Protein and Promotes Aβ Generation , 2011, The Journal of Neuroscience.

[10]  Michael I. Miller,et al.  Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss , 2010, Alzheimer's & Dementia.

[11]  Mark P Mattson,et al.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. , 2010, Biochimica et biophysica acta.

[12]  C. Gong,et al.  Deregulation of sphingolipid metabolism in Alzheimer's disease , 2010, Neurobiology of Aging.

[13]  C. Lyketsos,et al.  Serum sphingomyelins and ceramides are early predictors of memory impairment , 2010, Neurobiology of Aging.

[14]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[15]  R. Sears,et al.  Direct interaction between the inhibitor 2 and ceramide via sphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signaling , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  I. Akiguchi,et al.  Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis , 2005, Neuroscience.

[17]  B. Hermann,et al.  Middle-Aged Children of Persons With Alzheimer’s Disease: APOE Genotypes and Cognitive Function in the Wisconsin Registry for Alzheimer’s Prevention , 2005, Journal of geriatric psychiatry and neurology.

[18]  P. Schwille,et al.  Lipids as Modulators of Proteolytic Activity of BACE , 2005, Journal of Biological Chemistry.

[19]  B. Strooper,et al.  Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin , 2005, Nature Cell Biology.

[20]  M. Mattson,et al.  Alzheimer peptides perturb lipid-regulating enzymes , 2005, Nature Cell Biology.

[21]  Anders Wallin,et al.  Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. , 2005, Clinical chemistry.

[22]  Kai Simons,et al.  Model systems, lipid rafts, and cell membranes. , 2004, Annual review of biophysics and biomolecular structure.

[23]  M. Mattson,et al.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Mattson,et al.  Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia , 2004, Annals of neurology.

[25]  Xianlin Han,et al.  Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway , 2004, The Journal of Cell Biology.

[26]  L. Puglielli,et al.  Withdrawal: Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis , 2003, Journal of Biological Chemistry.

[27]  S H Ferris,et al.  Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly , 1999, Journal of geriatric psychiatry and neurology.

[28]  A. Bielawska,et al.  Long Chain Ceramides Activate Protein Phosphatase-1 and Protein Phosphatase-2A , 1999, The Journal of Biological Chemistry.

[29]  Arthur MacNeill Horton,et al.  Wechsler Memory Scale III , 1999 .

[30]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[31]  Y. Hannun.  Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[32]  M. Mattson,et al.  Ceramide Protects Hippocampal Neurons Against Excitotoxic and Oxidative Insults, and Amyloid β‐Peptide Toxicity , 1996, Journal of neurochemistry.

[33]  M. Goedert,et al.  Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase , 1995 .

[34]  I. Grundke‐Iqbal,et al.  Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A , 1994, Neuroscience.

[35]  R. Dobrowsky,et al.  Ceramide activates heterotrimeric protein phosphatase 2A. , 1993, The Journal of biological chemistry.

[36]  E. Tangalos,et al.  Visual Spatial Learning Test: Normative Data and Further Validation , 1992 .

[37]  J. Slotte,et al.  Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. , 1988, The Biochemical journal.

[38]  R. Ruff,et al.  Automatic Detection vs Controlled Search: A Paper-and-Pencil Approach , 1986, Perceptual and motor skills.

[39]  S. Gatt,et al.  Sphingomyelin suppresses the binding and utilization of low density lipoproteins by skin fibroblasts. , 1980, The Journal of biological chemistry.

[40]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[41]  C. Lyketsos,et al.  Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[42]  O. Spreen,et al.  Comprar A Compendium of Neuropsychological Tests - Administration, Norms, and Commentary | Esther Strauss | 9780195159578 | Oxford University Press , 2009 .

[43]  P. Quinn,et al.  The liquid-ordered phase in membranes. , 2009, Biochimica et biophysica acta.

[44]  J. Otvos,et al.  Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. , 2002, Clinical laboratory.

[45]  J. Brandt.  The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. , 1991 .